How Do You Make Decisions on Product Development?

3min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

In early days, actually decision making is much simpler. You just kind of talk to a few people or just make your quick all hand meeting everybody's in the same hall. But at the scale that we are in, I can tell you vast majority of decisions need to be made by people in our executive management team. So even if it's a cross functional kind of effort, we want one person to be what we call the DRI or the designated responsible individual for that initiative. And we try to make sure actually this culture of accountability and DRI ship goes deep in organization.

This week, we’re super excited to have AmirAli Talasaz, co-CEO and co-founder of Guardant Health, a leading precision oncology company focused on helping conquer cancer globally.

Founded in 2011, Guardant Health is focused on helping conquer cancer through the use of its proprietary blood-based tests, vast data sets and advanced analytics. Guardant’s solutions include treatment selection, recurrence detection and early detection of cancer. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.

Through multiple rounds of private financing, Guardant Health raised over $500 million from investors including Sequoia, Khosla, Lightspeed, OrbiMed, and Softbank, and Pear! and Guardant completed a successful IPO in October 2018.